| Index | — | P/E | 50.71 | EPS (ttm) | 0.21 | Insider Own | 1.66% | Shs Outstand | 259.63M | Perf Week | -2.47% |
| Market Cap | 2.77B | Forward P/E | 6.55 | EPS next Y | 1.62 | Insider Trans | 0.57% | Shs Float | 257.54M | Perf Month | -3.88% |
| Enterprise Value | 25.96B | PEG | 5.56 | EPS next Q | 0.38 | Short Float | 6.65% | Perf Quarter | -16.21% | ||
| Income | -50.00M | P/S | 2.59 | EPS this Y | 37.06% | Short Ratio | 2.70 | Perf Half Y | -21.52% | ||
| Sales | 1.07B | P/B | 0.91 | EPS next Y | 12.24% | ROA | -0.18% | Short Interest | 17.12M | Perf YTD | -23.98% |
| Book/sh | 11.76 | P/C | 2.78 | EPS next 5Y | 9.12% | ROE | -1.74% | 52W High | 14.93 -28.67% | Perf Year | -20.11% |
| Cash/sh | 3.82 | P/FCF | 11.10 | EPS past 3/5Y | -7.98% -18.64% | ROIC | 2.65% | 52W Low | 10.31 3.30% | Perf 3Y | 10.48% |
| Dividend Est. | 2.04 (19.15%) | EV/EBITDA | 44.00 | Sales past 3/5Y | — 18.14% | Gross Margin | 58.88% | Volatility | 2.15% 2.61% | Perf 5Y | -40.20% |
| Dividend TTM | 2.04 (19.15%) | EV/Sales | 24.29 | EPS Y/Y TTM | -86.04% | Oper. Margin | 67.53% | ATR (14) | 0.29 | Perf 10Y | -48.63% |
| Dividend Ex-Date | Oct 22, 2026 | Quick Ratio | 0.04 | Sales Y/Y TTM | 140.22% | Profit Margin | -4.65% | RSI (14) | 35.90 | Recom | 2.64 |
| Dividend Gr. 3/5Y | 8.27% 3.59% | Current Ratio | 0.04 | EPS Q/Q | 52.00% | SMA20 | -1.92% | Beta | 0.98 | Target Price | 12.00 |
| Payout | — | Debt/Eq | 7.93 | Sales Q/Q | 121.33% | SMA50 | -9.08% | Rel Volume | 0.89 | Prev Close | 10.89 |
| Employees | 28 | LT Debt/Eq | 0.00 | Earnings | Feb 01 | SMA200 | -17.50% | Avg Volume | 6.46M | Price | 10.65 |
| IPO Date | Feb 10, 1988 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -1.60% -10.50% | Net Debt/EBITDA | 39.32 | Volume | 5,738,684 | Change | -2.20% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jun-17-26 | Reiterated | BTIG | Buy | $16 → $15 |
| Apr-24-26 | Reiterated | UBS | Neutral | $13 → $15 |
| Jan-09-26 | Reiterated | BTIG | Buy | $16 |
| Jan-09-26 | Reiterated | Capital One Financial | $20 | |
| Oct-08-25 | Reiterated | UBS | Neutral | $13 |
| Sep-03-25 | Reiterated | UBS | Neutral | $13 |
| Jul-10-25 | Reiterated | UBS | Neutral | $13 |
| Jun-09-22 | Upgrade | Keefe, Bruyette & Woods | Market Perform → Outperform | |
| Dec-18-20 | Downgrade | Keefe, Bruyette & Woods | Outperform → Market Perform | |
| Nov-26-19 | Upgrade | Keefe, Bruyette & Woods | Market Perform → Outperform |
Dynex Capital, Inc. operates as a mortgage real estate investment trust (mREIT), primarily engaging in the leveraged acquisition of various mortgage-backed securities (MBS) within the United States. Its investment portfolio includes both agency and non-agency MBS. Agency MBS are distinguished by a principal payment guarantee from a U.S. government entity or a government-sponsored enterprise (GSE), such as Fannie Mae or Freddie Mac. In contrast, non-agency MBS do not possess this governmental backing. Dynex's holdings specifically encompass residential MBS, commercial MBS (CMBS), and certain CMBS interest-only instruments. For federal income tax purposes, the company holds the designation of a real estate investment trust. This status typically exempts Dynex Capital from federal corporate income tax liabilities, provided it distributes a minimum of 90% of its taxable earnings to its shareholders. Established in 1987, the firm maintains its corporate headquarters in Glen Allen, Virginia.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,069 | 534 | 318 | 133 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 440 | 0 | 0 | 0 | — | — | — | — | — | |
| Gross Profit | 630 | 534 | 318 | 133 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 46 | 0 | 35 | 31 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | -139 | -205 | -145 | -108 | — | — | — | — | — | |
| Operating Income | 723 | 738 | 428 | 209 | — | — | — | — | — | |
| Interest Expense | 752 | 419 | 314 | 215 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -21 | 0 | 0 | 0 | — | — | — | — | — | |
| Net Income Before Taxes | -50 | 319 | 114 | -6 | — | — | — | — | — | |
| Income Taxes | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Consolidated Net Income | -50 | 319 | 114 | -6 | — | — | — | — | — | |
| Net Income From Continuing Operations | -50 | 319 | 114 | -6 | — | — | — | — | — | |
| Net Income | -50 | 319 | 114 | -6 | — | — | — | — | — | |
| EPS (Recurring) | 0.22 | 2.49 | 1.50 | -0.25 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.22 | 2.49 | 1.50 | -0.25 | — | — | — | — | — | |
| EPS (Diluted) | 0.21 | 2.47 | 1.49 | -0.25 | — | — | — | — | — | |
| EBITDA | 590 | 740 | 429 | 212 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 50.71 | 5.67 | 8.49 | — | — | — | — | — | — | |
| Price To Sales Ratio | 2.51 | 3.25 | 2.82 | 5.18 | — | — | — | — | — | |
| Gross Margin | 58.93 | 100.00 | 100.00 | 100.00 | — | — | — | — | — | |
| Operating Margin | 67.63 | 138.20 | 134.59 | 157.14 | — | — | — | — | — | |
| Net Margin | -4.68 | 59.74 | 35.85 | -4.51 | — | — | — | — | — | |
| Shares Outstanding | 252 | 124 | 71 | 55 | — | — | — | — | — | |
| Market Capitalization | 2,684 | 1,737 | 898 | 689 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| BOSTON BYRON L | Co-CEO & Chairman of the Board | Oct 20 '26 | Buy | 10.89 | 9,180 | 99,970 | 892,747 | Oct 21 |
| Popenoe Smriti Laxman | Co-CEO and President | Oct 20 '26 | Buy | 13.05 | 12,000 | 156,560 | 541,098 | Oct 20 |
| Sartori Michael Andrew | Chief Financial Officer | Oct 20 '26 | Buy | 10.70 | 1,000 | 10,700 | 36,579 | Oct 20 |
| Connelly Terrence John JR | Chief Investment Officer | Sep 25 '26 | Buy | 11.18 | 2,500 | 27,950 | 58,695 | Sep 28 |
| Popenoe Smriti Laxman | Co-CEO and President | Feb 27 '26 | Buy | 12.19 | 2,000 | 24,380 | 550,626 | Mar 30 |
| Popenoe Smriti Laxman | Co-CEO and President | Sep 26 '25 | Buy | 12.16 | 4,260 | 51,784 | 407,338 | Sep 29 |
| COLLIGAN ROBERT S | CFO and COO | Sep 26 '25 | Buy | 12.12 | 4,200 | 50,904 | 120,857 | Sep 29 |
| COLLIGAN ROBERT S | EVP and CFO | Mar 14 '23 | Buy | 12.16 | 8,000 | 97,280 | 40,416 | Mar 15 |
| BOSTON BYRON L | CEO and Co-CIO | Oct 26 '22 | Buy | 11.61 | 2,500 | 29,025 | 402,634 | Oct 27 |
| BOSTON BYRON L | CEO and Co-CIO | Oct 25 '22 | Buy | 10.92 | 12,000 | 130,998 | 400,134 | Oct 27 |
| Popenoe Smriti Laxman | President and Co-CIO | Sep 01 '22 | Buy | 15.50 | 2,000 | 31,000 | 124,526 | Sep 06 |
| COLLIGAN ROBERT S | EVP and CFO | Aug 23 '22 | Buy | 15.84 | 10,000 | 158,400 | 10,000 | Aug 24 |
| BOSTON BYRON L | CEO and Co-CIO | Aug 22 '22 | Buy | 15.54 | 1,928 | 29,961 | 3,095 | Aug 24 |
| BOSTON BYRON L | CEO and Co-CIO | Jun 13 '22 | Buy | 15.25 | 6,562 | 100,070 | 388,134 | Jun 14 |
| BOSTON BYRON L | CEO and Co-CIO | May 17 '22 | Buy | 16.27 | 1,167 | 18,986 | 1,167 | May 19 |